Budden

Try Grokipedia.com. Post links on your social media and websites.

How does OpenAI balance long-term research bets with product-forward research fundamentals? I’ve been getting this question a lot lately, usually framed as a suggestion that Jakub (@merettm) and I are pushing an increasingly product-focused agenda. That characterization is simply wrong. Foundational research has been core to OpenAI from the start, and today we run a research program with hundreds of exploratory projects - much like the ones that led to our reasoning-model breakthrough. The majority of our compute is allocated to foundational research and exploration - and not product milestones. Anyone who has spent time with me or Jakub knows we are the last people in the world who would push for the advancement of products over the advancement of research. We’re in the business of creating an automated scientist, and capabilities that were considered grand challenges just a few years ago (like IMO-level mathematical reasoning) now emerge as normal parts of the research process. We’re also seeing our models accelerate researchers worldwide, helping advance work across biology, mathematics, physics, and even our own research. Jakub and I put a lot of effort into ensuring that research stays focused on uncovering algorithms that will scale to the compute we’ll have a year from now. We protect mindshare and amplify discourse on exploratory work. We do this while recognizing that we’re also a deployment company - and that deployment gives us access to even larger-scale compute, richer feedback, and more room for exploration. Our researchers are passionate about having their work out in the world, and a special slice of our org is dedicated to making sure our deployments are delightful for end users. Our goal isn’t to turn research into a quarterly race. It’s to build a durable research engine - one that compounds learning over time and consistently turns long-horizon exploration into real, measurable advances, while ensuring those advances become valuable in the real world. That’s the roadmap we’re executing on. And while there have been ups and downs over the last decade (as you expect with any research program), I think most of our researchers would share my strong optimism today.